Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page's Locations section was updated with a broad list of study sites across the United States and international locations, expanding enrollment options. It also shows removals of several prior site blocks, indicating a reorganization of site listings.SummaryDifference1%

- Check15 days agoChange DetectedThe page now displays 'Last Update Posted (Estimated)' instead of 'Last Update Posted', a minor labeling change to the timestamp field. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedThe study location list has been updated to 130 sites, with new centers in Sichuan, Charlotte, Tampa, and Singapore, among others. Several locations were removed, including Antwerp University Hospital, Sichuan Provincial Cancer Hospital, TU Dresden, Gdańsk, and the National Cancer Centre.SummaryDifference0.7%

- Check30 days agoChange DetectedSite revision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check37 days agoChange DetectedNote added that PubMed-generated publications are automatically filled and may not relate to the study. Revision label updated to v3.3.1; the previous PubMed note and v3.2.0 revision have been removed.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Tainan, Taiwan, 70457 to the Locations and removed Tainan City, Taiwan, 70457; the government funding lapse notice text in the page header was deleted.SummaryDifference0.2%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.